Corbus Pharmaceuticals Holdings, Inc. (CRBP) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - CRBP

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y GrowthN/A

5Y CAGR-57.15%

10Y CAGR-24.35%

Equity

1Y Growth3.56%

5Y CAGR26.65%

10Y CAGR32.29%

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	-77.6%	-84.4%	-43.2%	-14.3%	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	-89.1%	-9.6%	17.3%	43.4%	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	649.5%	284.9%	166.4%	N/A	N/A	N/A	N/A	N/A
FY 2018 Dec 31, 2018	97.6%	58.8%	95.2%	N/A	N/A	N/A	N/A	N/A
FY 2017 Dec 31, 2017	27.7%	94.0%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2016 Dec 31, 2016	194.8%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2015 Dec 31, 2015	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2014 Dec 31, 2014	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2013 Dec 31, 2013	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2012 Dec 31, 2012	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - CRBP

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Corbus Pharmaceuticals Holdings, Inc.

Compare with peers

Explore

Growth Analysis - CRBP

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Corbus Pharmaceuticals Holdings, Inc.

Compare with peers

Explore